JOINT FILING AGREEMENT
Exhibit
2
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange
Act of 1934, as
amended, each of the undersigned Reporting Persons hereby agrees
to the joint
filing, along with all other such Reporting Persons, on behalf
of each of them
of a statement on Schedule 13G (including amendments thereto)
with respect to
the Common Stock, $0.001 par value, of Abraxis BioScience, Inc.,
and that this
Agreement be included as an Exhibit to such joint filing. This
Agreement may be
executed in any number of counterparts, all of which taken together
shall
constitute one and the same instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this
Agreement as of
this 26th
day of
September, 2008.
|
|||
|
By:
|
X.
X. Xxxx & Co., L.P., as
managing
member
|
|
|
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | ||
|
|
|
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
X. X. Xxxx & Co., L.P. | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
Xxxxx X. Xxxx | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Attorney-in-Fact
for Xxxxx X.
Xxxx
|